BIOMARKERS FOR DIAGNOSIS, PROGNOSIS, PREVENTION, IMPROVEMENT OR RELIEF IN THE TREATMENT OF CHILDHOOD B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

Patent number:

WO22129668

Andalucía.svg
No items found.

The present invention describes the use of lncRNA AL133346.1, optionally combined with mRNAs, for the diagnosis, prognosis, prevention, improvement, relief or treatment of childhood B-cell acute lymphoblastic leukemia, and methods, kits and devices based on said use.

Countries:
Spain
Regions:
Andalusia
Centers:
UNIVERSIDAD DE GRANADA
Other entities:
Sectors:
Health
Subsectors:
Biotechnology
TRL Level:
TRL 2 – technology concept formulated
BRL Level:
PDF Link:
Download here
Video Link:
Watch it here
Sustainable Development Goal:
Applications

Use of lncRNA and mRNA as diagnostic biomarkers for pediatric B-ALL. Support in the therapeutic strategy of patients with pediatric B-ALL. No specific equipment is necessary. Simple method.

Comments

Other related patents

Health
Food & Agro

FEEDING AND FOOD PROCEDURE FOR PINK-RED SKIN FISH FROM AQUACULTURE, TO OBTAIN IN THEM A COLORING AND EXTERNAL APPEARANCE SIMILAR TO THOSE ORGANISMS WHEN THEY ARE OBTAINED DIRECTLY FROM THE SEA THROUGH EXTRACTIVE FISHING. (MACHINE-TRANSLATION BY GOOGLE TRAN

Countries
Spain
Know more
Health
New & Sustainable Materials
Construction

New Basanite Nanoparticle Production Method

Countries
Spain
Know more
Health

USE OF A BORON CLUSTER AS TRANSMEMBRANE CARRIER

Countries
Spain
Germany
Know more
Get back to patents directory